The Implantable Cardioverter Defibrillator

Cardiac Pacing and ICDs, Fourth Edition

Volumn , Issue , 2007, Pages 380-414

  Gold, Michael R ^a,b  

^a Division of Cardiology   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Annual mortality; Antitachycardia pacing; Bipolar leads; Epicardial lead systems; ICD implantation

Indexed keywords

EID: 84889393824     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470750674.ch8     Document Type: Chapter

References (82)

1. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 20002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices: executive summary article. Circulation 2002;106:2145-2161.
2. The Antiarrhythmic Versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576-1583.
3. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS).A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
4. Sheldon R, Connolly S, Krahn A, et al. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-1664.
5. Kuck K-H, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754.
6. Moss A, Hall J, Cannom D, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias. N Engl J Med 1997;335:1933-1940.
7. Buxton AE, Lee DL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341: 1882-1890.
8. Gold MR, Nisam S. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT. Pacing Clin Electrophysiol 2000;23:1981-1985.
9. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337:1569-1575.
10. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-1945.
11. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158.
12. Moss AJ, Zareba W, Hall WJ, et al: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
13. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999;33:1964-1970.
14. Andrews NP, Fogel RI, Pelargonio G, et al. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 1999;34:2023-2030.
15. Nademanee K, Veerakul G, Mower M, et al. Defibrillator versus b-blockers for unexplained death in Thailand (DEBUT): A randomized clinical trial. Circulation 2003;107:2221-2226.
16. Pacifico A, Wheelan KR, Nasir N, et al. Long-term follow-up of cardioverterdefibrillator implanted under conscious sedation in the prepectoral subfascial position. Circulation 1997;95:946-950.
17. Gold MR, Peters RW, Johnson JW, et al. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. J Am Coll Cardiol 1996;28:1278-1282.
18. Larsen GC, Manolis AS, Sonnenberg FA, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323-1334.
19. Mirowski M, Mower MM, Gott VL, et al. Feasibility and effectiveness of low-energy catheter defibrillation in man. Circulation 1973;47:79-85.
20. Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
21. Ellenbogen KA,Wook MA, Shepard RK, et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 2003;41:73-80.
22. The DAVID Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002;288:3115-3123.
23. Fitzpatrick AP, Lesh MD, Epstein LM, et al. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 1994;89:2503-2508.
24. Gold MR, Froman D, Kavesh NG, et al. A comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of costs and outcomes. J Interven Cardiac Eletrophysiol 1998;2:345-349.
25. Hayes DL, Naccarelli GV, Furman S, et al. NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. PACE 2003; 26:1556-1562.
26. Roelke M, O'Nunain SS, Osswald S, et al. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:973-979.
27. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with pectoral implantation of cardioverter-defibrillators. Pacing Clin Electrophysiol 1997;20:208-211.
28. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol 1992;15:932-949.
29. Gold MR, Higgins S, Klein R, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation. Primary results from the Low Energy Safety Study (LESS). Circulation 2002;105:2043-2048.
30. Shorofsky SR, Peters RW, Rashba EJ, Gold MR. Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. PACE 2004;27:218-220.
31. Gold MR, Breiter D, Leman R, et al. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. PACE 2003;26:483-486.
32. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001;103:2159-2164.
33. Singer I, Adams L, Austin E. Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1993;16:1070-1079.
34. Berul CI, Callans DJ, Schwartzman DS, et al. Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control. J Am Coll Cardiol 1995;25:431-436.
35. Cooklin M, Tummala RV, Peters RW, et al. Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J 1999;138:133-136.
36. Gold MR, Shorofsky SR.Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol 1996;7:570-580.
37. Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 1996;7:542-558.
38. Peters RW, Cooklin M, Brockman R, et al. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Intervent Cardiac Electrophysiol 1998;2:367-370.
39. Peters RW, Foster AH, Shorofsky SR, et al. Spurious discharges due to late insulation break in endocardial sensing leads for cardioverter defibrillators. Pacing Clin Electrophysiol 1995;18:478-481.
40. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 1995;6:832-1851.
41. Dijkman B,Wellens HJJ. Dual chamber arrhythmia discrimination in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11:1105-1115.
42. Deisenhofer I, Kolb C, Ndrepepa G, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12:134-142.
43. Gold MR, Shorofsky SR, Thompson JA, et al. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002;13:1092-1097.
44. Newman D, Dorian P, Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993;21:1413-1418.
45. Schaumann A, Muhlen FVZ, Herse B, et al. Empirical versus tested antitachycardia pacing in implanted cardioverter defibrillators: a prospective study including 200 patients. Circulation 1998;97:66-74.
46. Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801.
47. Bardy GH, Poole JE, Kudenchuk PJ, et al. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion. Circulation. 1993 Jun;87(6):1889-1896.
48. Dillon SM.The electrophysiologic effects of defibrillation shocks. In: Kroll MW, Lehmann MH, eds. Implantable Cardioverter Defibrillator Therapy. The Engineering Clinical Interface. Norwell: Kluwer Academic 1996:61-.
49. Gold MR, Shorofsky SR. Strength-duration relationship for human transvenous defibrillation. Circulation 1997;96:3517-3520.
50. Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304-310.
51. Block M, Hammel D, Bocker D, et al. A prospective randomized cross-over comparison of mono-and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994;5:581-590.
52. Strickberger SA, Hummel JD, Horwood LE, et al. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J Am Coll Cardiol 1994;24:1069-1072.
53. Shorofsky SR, Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am J Cardiol 1996;78:313-316.
54. Olsovsky MR, Shorofsky SR, Gold MR. Effect of shock polarity on biphasic defibrillation thresholds using an active pectoral lead system. J Cardiovasc Electrophysiol 1998;9:350-354.
55. Strickberger SA, Man KC, Daoud E, et al. Effect of first-phase polarity of biphasic shocks on defibrillation threshold with a single transvenous lead system. J Am Coll Cardiol 1995;25:1605-1608.
56. Bardy GH, Poole JE, Kudenchuk PJ, et al. A prospective randomized comparison in humans of biphasic waveform 60-mF and 120-mF capacitance pulses using a unipolar defibrillation system. Circulation 1995;91:91-95.
57. Swerdlow CD, Kass RM, Davie S, et al. Short biphasic pulses from 90 microfarad capacitors lower defibrillation threshold. Pacing Clin Electrophysiol 1996;19:1053-
58. Poole J, Kudenchuk P, Dolack G, et al. A prospective randomized comparison in humans of 90mF and 120mF biphasic pulse defibrillation using a unipolar pectoral transvenous defibrillation system. J Cardiovasc Electrophysiol 1995;6:1097-1100.
59. Block M, Hammel D, Bocker D, et al. Internal defibrillation with smaller capacitors: a prospective randomized cross-over comparison of defibrillation efficacy obtained with 90-mF and 125-mF capacitors in humans. J Cardiovasc Electrophysiol 1995;6:333-342.
60. Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
61. Haffajee C, Martin D, Bhandari A, et al. A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system. Pacing Clin Electrophysiol 1997;20:215-219.
62. Poole JE, Bardy GH, Dolack GL, et al. A prospective randomized evaluation of implantable cardioverter-defibrillator size on unipolar defibrillation system efficacy. Circulation 1995;92:2940-2943.
63. Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996;78:540-543.
64. Gold MR, Foster AH, Shorofsky SR. Lead system optimization for transvenous defibrillation. Am J Cardiol 1997;80:1163-1167.
65. Gold MR, Olsovsky MR, Pelini MA, et al. Comparison of single-and dualcoil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;31:1391-1394.
66. Stajduhar KC, Ott GY, Kron F, et al. Optimal electrode configuration for pectoral transvenous implantable defibrillation: a prospective randomized study. J Am Coll Cardiol 1996;27:90-94.
67. Gold MR, Olsovsky MR, DeGroot PJ, et al. Optimization of transvenous coil position for active can defibrillation thresholds. J Cardiovasc Electrophysiol 2000;11: 25-29.
68. Kirk MM, Shorofsky SR, Gold MR. Right sided active pectoral pulse generators do not reduce defibrillation thresholds. Pacing Clin Electrophysiol 1999;22:747.
69. Neuzner J, Schwarz T, Strasser R, et al. Effect of the addition of an abdominal hot can cardioverter/defibrillator pulse generator on the defibrillation energy requirements in a single-lead endocardial defibrillation system. Eur Heart J 1997;18: 1655-1658.
70. Raitt MH, Johnson G, Dolack GL, et al. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol 1995;25:1576-1583.
71. Hodgson DM, Olsovsky MR, Shorofsky SR, et al. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system. PACE 2002;25: 408-413.
72. Higgins SL, Alexander DC, Kuypers CJ, et al. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds. Pacing Clin Electrophysiol 1995;18:1540-1548.
73. Epstein AE, Ellenbogen KA, Kirk KA, et al. Clinical characteristics and outcome of patients with high defibrillation thresholds: a multicenter study. Circulation 1992;86: 1206-1216.
74. Wetherbee JN, Chapman PD,Troup PJ, et al. Long term internal cardiac defibrillation threshold stability. Pacing Clin Electrophysiol 1989;12:443-450.
75. Venditti FJ, Martin DT,Vassolas G, et al. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation 1994;89:216-223.
76. Gold MR, Kavesh NG, Peters RW, et al. Biphasic waveforms prevent the chronic rise of defibrillation thresholds with a transvenous lead system. J Am Coll Cardiol 1997;30:233-236.
77. Tokano T, Pelosi F, Flemming M, et al. Long-term evaluation of the ventricular defibrillation energy requirement. J Cardiovasc Electrophysiol 1998;9:916-920.
78. Dijkman B,Wellens HJ. Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000;11: 1196-1205.
79. Gold MR, Sulke N, Schwartzman DS, et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-1253.
80. Adler SW,Wolpert C,Warman E, et al. Efficacy of pacing therapies for treating atrail tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001;104:887-892.
81. Friedman PA, Kijkman B,Warman EN, et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-1028.
82. Newman DM, Dorain P, Paquette M, et al.The effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient perceived healthrelated quality of life. Am Heart J 2002;145:841-846.